Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)

MARLBOROUGH, Mass., April 30, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL siRNA gene silencing technology is d

Phio Pharmaceuticals Apr 30 12:00

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s

BenzingaApr 24 01:53

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GainersImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. The company's market cap stands at $4.4 billion. Nuwellis (NASDAQ:NUWE) shares increased by

BenzingaApr 23 20:06

12 Health Care Stocks Moving In Monday's After-Market Session

GainersNuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. The company's market cap stands at $3.2 million. Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 7.42% to

BenzingaApr 23 04:31

Why Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?

Phio Pharmaceuticals Corp (NASDAQ:PHIO) shares are trading higher after the company announced it is presenting new data about its lead clinical product candidate, PH-762, an INTASYL compound.The share

BenzingaApr 23 02:29

Intratumoral Injection of Phio's PH-762 Significantly Inhibits Tumor Growth in Murine Tumor Models and May Generate Memory-specific T Cells

-Injection in murine tumors shows the compound is well tolerated-Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment of cSCC, melanoma, or Merkel cell carcinomaMARL

Phio Pharmaceuticals Apr 22 12:00